ARNA

Arena Pharmaceuticals, Inc. News Headlines

$4.44
*  
0.03
0.67%
Get ARNA Alerts
*Delayed - data as of Jul. 2, 2015  -  Find a broker to begin trading ARNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Arena - Belviq Advertsing Closes Out Year With Big Push
12/29/2014 1:13:00 PM - Seeking Alpha






Is Vivus Headed Towards An Unfortunate Ending?
12/27/2014 8:27:00 AM - Seeking Alpha






Novo Nordisk Enters Anti-Obesity Space With New FDA Approval
12/24/2014 7:46:00 AM - Seeking Alpha




Contrave Prescriptions Still Rising In A Down Week
12/22/2014 3:47:00 PM - Seeking Alpha


Orexigen - Contrave Script Numbers Remain Impressive
12/22/2014 3:31:00 PM - Seeking Alpha






New Obesity Drug Available Soon
12/21/2014 11:22:40 PM - Motley Fool








Contrave Sales Continue To Impress
12/12/2014 4:26:00 PM - Seeking Alpha


Arena: Belviq Sales See Pleasant Rebound
12/12/2014 4:05:00 PM - Seeking Alpha


Assessing The Beginnings Of The Orexigen Launch Of Contrave
12/10/2014 1:09:00 PM - Seeking Alpha






Arena's Belviq - Regulatory Update And A Recall
12/8/2014 9:01:00 AM - Seeking Alpha




Will Diabetes Drugs Enter The Anti-Obesity Space?
12/7/2014 6:58:00 AM - Seeking Alpha